These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27015045)

  • 1. Targeting astrocytes in bipolar disorder.
    Peng L; Li B; Verkhratsky A
    Expert Rev Neurother; 2016 Jun; 16(6):649-57. PubMed ID: 27015045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.
    Song D; Li B; Yan E; Man Y; Wolfson M; Chen Y; Peng L
    Neurochem Res; 2012 Nov; 37(11):2524-40. PubMed ID: 22965852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does conventional anti-bipolar and antidepressant drug therapy reduce NMDA-mediated neuronal excitation by downregulating astrocytic GluK2 function?
    Peng L; Li B; Du T; Wang F; Hertz L
    Pharmacol Biochem Behav; 2012 Feb; 100(4):712-25. PubMed ID: 21463649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
    Bazinet RP
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1104-9. PubMed ID: 19754461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with anti-bipolar drugs suppresses glutamate release from astroglial cultures.
    Liu Z; Song D; Yan E; Verkhratsky A; Peng L
    Amino Acids; 2015 May; 47(5):1045-51. PubMed ID: 25676933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific.
    Li B; Gu L; Zhang H; Huang J; Chen Y; Hertz L; Peng L
    Psychopharmacology (Berl); 2007 Oct; 194(3):333-45. PubMed ID: 17594078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder.
    Prien RF; Rush AJ
    Biol Psychiatry; 1996 Aug; 40(3):215-20. PubMed ID: 8830955
    [No Abstract]   [Full Text] [Related]  

  • 8. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocytes in Bipolar Disorder.
    Butt AM; Rivera AD
    Adv Neurobiol; 2021; 26():95-113. PubMed ID: 34888832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
    Emilien G; Maloteaux JM; Seghers A; Charles G
    Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of thymoleptics in the treatment of bipolar disorders].
    Sechter D
    Encephale; 1996; 22(1):65-8. PubMed ID: 8681877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar disorder.
    Belmaker RH
    N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
    [No Abstract]   [Full Text] [Related]  

  • 14. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
    Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological issues in the treatment of bipolar disorder: focus on mood-stabilizing compounds.
    Potter WZ; Ketter TA
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S51-6. PubMed ID: 8500079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bipolar disorder in older adults.
    Sajatovic M
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):865-73. PubMed ID: 12221662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for L-channel-mediated increase in [Ca(2+)]i and its reduction by anti-bipolar drugs in cultured astrocytes combined with its mRNA expression in freshly isolated cells support the importance of astrocytic L-channels.
    Yan E; Li B; Gu L; Hertz L; Peng L
    Cell Calcium; 2013 Nov; 54(5):335-42. PubMed ID: 24079970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons.
    Li B; Zhang S; Li M; Zhang H; Hertz L; Peng L
    Neuropharmacology; 2009 Sep; 57(4):375-85. PubMed ID: 19596362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of bipolar depression and mania.
    Cookson JC
    Br J Hosp Med; 1985 Sep; 34(3):172-5. PubMed ID: 2865999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatives to lithium in the treatment of bipolar disorder.
    Keltner NL; Folks DG
    Perspect Psychiatr Care; 1991; 27(2):36-7. PubMed ID: 1788043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.